8-K
filed May 12, 2023, 7:59 PM ET
ticker AVAH
CIK 0001832332
other material
confidence high
sentiment neutral
materiality 0.60
Aveanna stockholders approve reverse stock split; three directors elected
Aveanna Healthcare Holdings, Inc.
- Stockholders elected Rodney D. Windley, Christopher R. Gordon, Steven E. Rodgers as Class I directors.
- Approved charter amendment authorizing reverse stock split at ratio between 1-for-5 and 1-for-20, board to set exact ratio.
- Ratified Ernst & Young as independent auditor for fiscal 2023.
- Advisory vote on executive compensation passed with 168.4M votes for.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Aveanna Healthcare Holdings, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 30, 2023 at the 2023-05-10 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-05-10
Exact text from the filing
Proposal 2: Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 30, 2023: Votes Votes Broker For Against Abstentions Non-Votes 178,546,739 22,205 51,587 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Aveanna Healthcare Holdings, Inc. shareholders approved Approval of an amendment to the Company’s Charter to effect a Reverse Stock Split with respect to the Company’s issued and outstanding common stock at any time prior to December 29, 2023, within a pre-approved ratio Range (1 for 5 to 1 for 20) at the 2023-05-10 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2023-05-10
Exact text from the filing
Proposal 4: Approval of an amendment to the Company’s Charter, in the form set forth in Appendix A of the Proxy Statement, to effect a Reverse Stock Split with respect to the Company’s issued and outstanding common stock at any time prior to December 29, 2023, within a pre-approved ratio Range (1 for 5 to 1 for 20), with the Effective Ratio to be a ratio within the Range to be determined at the discretion of the Company’s Board of Directors and included in a public announcement by the Company before the effectiveness of the Reverse Stock Split: Votes Votes Broker For Against Abstentions Non-Votes 176,081,717 2,496,049 42,765 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Aveanna Healthcare Holdings, Inc. shareholders approved Approval of a non-binding advisory resolution approving the compensation of the Company’s named executive officers as disclosed in the Company’s 2023 Proxy Statement for the Annual Meeting at the 2023-05-10 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-05-10
Exact text from the filing
Proposal 3: Approval of a non-binding advisory resolution approving the compensation of the Company’s named executive officers as disclosed in the Company’s 2023 Proxy Statement for the Annual Meeting: Votes Votes Broker For Against Abstentions Non-Votes 168,402,819 1,910,610 595,313 7,711,789
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.98
Aveanna Healthcare Holdings, Inc. shareholders approved Election of three Class I directors to the Board of Directors for three-year terms at the 2023-05-10 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-05-10
Exact text from the filing
Proposal 1: Election of three Class I directors to the Board of Directors of the Company for three-year terms to hold office until the Company’s 2026 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Votes Votes Broker Director For Withheld Non-Votes Rodney D. Windley 158,576,161 12,332,581 7,711,789 Christopher R. Gordon 163,952,678 6,956,064 7,711,789 Steven E. Rodgers 167,606,343 3,302,399 7,711,789
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.